ESC 365 - Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome

ESC Professional Premium Access

Comparison between ticagrelor and clopidogrel in high bleeding risk patients with acute coronary syndrome

Session: The role of bleeding in determining antithrombotic treatment in acute coronary syndromes

Topic: Pharmacotherapy

Speaker: Doctor J. Tjerkaski (Stockholm, SE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Jonathan Tjerkaski

Karolinska Institute, Stockholm (Sweden)

0 follower

1 more presentation in this session

State-of-the-art lecture in the role of bleeding in determining DAPT .

Speaker: Professor M. Valgimigli (Lugano, CH)

Access the full session

The role of bleeding in determining antithrombotic treatment in acute coronary syndromes

Speakers: Doctor J. Tjerkaski, Professor M. Valgimigli

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources